Controversy is brewing, again, about generic substitution of antiepileptic drugs for seizures

July 2007

Controversy is brewing, again, about generic substitution of antiepileptic drugs for seizures.

The FDA and most state Boards of Pharmacy say it's okay to switch between most generics...even those for which the difference between the toxic dose and the therapeutic dose is very close.

But some policy makers want to limit generic substitution of antiepileptics.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote